Servier Pharmaceuticals announced the appointment of Peter Adamson as Global Head of Oncology Clinical Development.
Adamson is a recognized physician-scientist and executive leader with extensive expertise in oncology drug development, clinical pharmacology, and translational research. He has held leadership positions in academia, government, and industry, overseeing complex clinical programs and large research initiatives.
Servier aims to advance its mission of delivering transformative cancer therapies under Adamson’s leadership.
Leave a Reply